We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Beer necessities

19 February 2020 By Jeffrey Goldfarb

A pushy investor makes a persuasive case for the $18 bln brewer to improve governance and ditch pharma and beauty holdings. The company offered a weaker board shakeup and pay-plan revision. In a country renowned for corporate rigidity, the sops could prevail in a proxy battle.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)